📌 Key Takeaways
- At IMCAS World Congress 2026 (Paris), Galderma presented findings from a 9-country survey of 4,300+ peri- and post-menopausal women.
Women experience an average of 3 distinct skin changes during menopause —
and more than 30% said they wished they had known about these changes in their 30s. - The root cause is estrogen decline disrupting collagen production.
Around menopause, annual collagen loss accelerates from 1–2% to as much as 2–3% per year —
a compounding effect that begins years before symptoms appear. - “Menopausal skin care” should not be framed as damage control.
It is best understood as a preventive collagen and estrogen strategy starting in your 30s.
“My skin suddenly lost its firmness.”
“Dryness got worse — foundation just won’t sit right anymore.”
“Something about my skin texture has just… changed.”
These are among the most common complaints women bring to aesthetic clinics in their 40s.
Most assume it’s a skincare problem.
But what if it were a biological process that could have been anticipated — and prepared for — years earlier?
INDEX
What the 4,300-Woman Survey Found
(dryness, loss of elasticity, uneven tone, and more)
Why Menopause Transforms Skin: The Estrogen–Collagen Connection
Estrogen is far more than a reproductive hormone.
For the skin, it functions as the master regulator of structural maintenance.
Its roles in skin biology include:
- Stimulates collagen synthesis and inhibits collagen breakdown
- Promotes hyaluronic acid production — maintaining deep hydration
- Preserves skin thickness and elasticity
- Sustains dermal blood flow, ensuring nutrient delivery
- Provides antioxidant and anti-inflammatory protection
When estrogen drops sharply around menopause, all of these functions decline simultaneously.
Research suggests that annual collagen loss — already running at 1–2% from the mid-20s —
can accelerate to 2–3% per year during the 5–10 years surrounding menopause.
The 3 Skin Changes — Explained
Change 1 — Dryness & Barrier Breakdown
Estrogen decline → reduced hyaluronic acid synthesis → loss of moisture retention.
“My usual toner just doesn’t feel like enough anymore” —
this is the biological explanation behind that shift.
Skin barrier function also weakens, increasing sensitivity to external irritants.
Change 2 — Loss of Firmness & Elasticity
Collagen and elastin production drop sharply → skin loses its structural tension.
“My cheeks feel softer than they used to” or “my jawline looks less defined” —
these are the visible consequences.
Collagen has been declining since the mid-20s, but menopause accelerates the process significantly.
Change 3 — Dullness & Uneven Tone
Reduced dermal blood flow and weakened antioxidant defense → dullness and hyperpigmentation become more visible.
Slower cell turnover means dead skin cells accumulate on the surface,
further dulling overall complexion.
Why “Starting in Your 30s” Actually Matters
The reason more than 30% of survey respondents wished they had known about these changes in their 30s
is straightforward: menopausal skin changes don’t arrive suddenly.
They accumulate over 10 to 20 years.
By the time the changes become visible in the 40s,
the underlying biological decline has already been underway for years.
- Support collagen production now: Biostimulators (Sculptra, Radiesse), PDRN, and topical vitamin C
function as proactive collagen preservation strategies — not just corrective treatments. - Maintain dermal hydration with skin boosters: Hyaluronic acid-based skin boosters
help preserve the moisture-retaining environment of the dermis before it degrades. - Monitor hormonal shifts early: Regular measurement of estrogen and progesterone levels
allows you to track the perimenopause transition before symptoms become pronounced. - Commit to photoprotection: UV damage compounds estrogen-driven collagen loss.
Consistent sun protection is the most fundamental preventive strategy available.
Very few articles in the aesthetic medicine space connect menopause directly to skin biology in a clinically grounded way.
But this is information that matters to every reader NERO serves.
When you notice your skin changing and understand that estrogen decline may be the underlying cause,
the decision tree becomes clear:
adjust your skincare, visit an aesthetic clinic, or consult a gynecologist —
the right path becomes visible.
Menopausal skin care does not begin in your 40s.
The choices you make in your 30s are already designing the skin you will have at 45.
Summary
- Galderma’s survey presented at IMCAS 2026 (9 countries, 4,300+ women) found that women experience
an average of 3 skin changes during menopause — including dryness, loss of firmness, and dullness. - The root cause is a simultaneous decline in collagen production, moisture retention, and dermal blood flow,
all driven by falling estrogen levels. - More than 30% of respondents wished they had known about these changes in their 30s.
Because menopausal skin changes accumulate over 10–20 years, early preventive action is clinically rational. - A combined approach — biostimulators, skin boosters, hormonal monitoring, and UV protection —
represents the most evidence-aligned strategy for designing skin health before menopause arrives.
but the underlying biological decline — driven by gradual estrogen reduction —
begins in the late 30s to early 40s during perimenopause.
Collagen loss, which starts in the mid-20s at 1–2% per year,
accelerates to approximately 2–3% per year around menopause.
women experience an average of 3 skin changes during menopause.
The most common are: increased dryness and barrier breakdown,
loss of firmness and elasticity, and dullness or uneven skin tone.
All three are directly linked to declining estrogen levels.
to support collagen production, hyaluronic acid skin boosters for deep hydration,
and consistent photoprotection to prevent UV-compounded collagen loss.
Hormonal monitoring (estrogen and progesterone levels) is also recommended
to track the perimenopause transition and inform treatment timing.
Sources:
Galderma, “Galderma tackles menopause-related skin changes with global survey and clinical trial inclusivity,” January 30, 2026 (IMCAS 2026 World Congress, Paris) /
Plastic Surgery Practice, “Survey Reveals Knowledge Gap on Menopause-Related Skin Changes,” February 4, 2026 /
Cosmeticsdesign-europe, “Q&A: Galderma global insights into menopause-related skin changes,” February 10, 2026 /
Visconi B et al., “Managing menopausal skin change: A narrative review,” J Cosmet Dermatol 2025;24:E70393 /
Fabi SG et al., “Round table discussion: Aesthetic treatment considerations for the perimenopausal & menopausal patient,” J Cosmet Dermatol 2026;15:E70726 /
Physicians Weekly, “HRT’s Role in Skin Health During Menopause,” April 2026
